# Main Sequence Ventures

Source: https://capitalatlas.ai/funds/main-sequence-ventures

> Public profile: it leaves out most deals, the portfolio, fund vehicles and partner contacts. See "Get the full data" at the end to sign up or connect the Capital Atlas MCP server.

Main Sequence Ventures invests in Australian founders making use of the publicly-funded research sector. The firm provides seed through Series B capital to start-ups, spin-off companies, and SMEs with a Deep Tech focus. With over 55investments since 2017, Main Sequence manages their portfolio companies through the CSIRO Innovation Fund 1, 2 and 3, which is part of the Australian's Government's National Innovation and Science Agenda.

## Facts

- Type: Venture Capital Firm
- Headquarters: Sydney, Australia
- Founded: 2017
- Website: http://www.mseq.vc
- Estimated dry powder: $153.1M
- AUM: $702.6M
- Latest fund: Main Sequence Fund 3, $295.5M
- Estimated cheque size: $1.8M–$12.2M
- Stages: Seed, Series A, Series B, Series C, Series D, Series E, Early Stage
- Sectors: Diversified, Information Technology
- Regions: Australasia
- Last seen investing: Sep 2026
- Investments in the last 12 months: 19

## Recent investments (newest 5 of 134)

- Sep 2026: Metacognition Pty Ltd (Unspecified Round, $7.2M)
- Aug 2026: Facet Amtech Pty Ltd (Seed, $2.1M)
- Aug 2026: Kinoxis Therapeutics Pty Ltd (Unspecified Round, $4.8M)
- Aug 2026: Zabidou Pty Ltd. (Seed, $2.5M)
- Jul 2026: Emesent Pty Ltd (Unspecified Round, $10M)

## Questions

### How much does Main Sequence Ventures invest per deal?

Based on the size of its funds, Main Sequence Ventures writes estimated cheques of $1.8M–$12.2M. Lead cheques usually sit at the top of that range and follow-on cheques lower.

### What stages does Main Sequence Ventures invest in?

Main Sequence Ventures has invested at Seed, Series A, Series B, Series C, Series D and Series E. Its most frequent rounds on record are Seed, Series A and Series B.

### How much capital does Main Sequence Ventures have left to invest?

Main Sequence Ventures has an estimated $153.1M in dry powder: capital it has raised but not yet invested.

### What has Main Sequence Ventures invested in recently?

Recent investments include Metacognition Pty Ltd, Facet Amtech Pty Ltd and Kinoxis Therapeutics Pty Ltd. It made 19 investments in the last 12 months.

### Where is Main Sequence Ventures based?

Main Sequence Ventures is headquartered in Sydney, Australia. It has 1 other office.

### How do I contact Main Sequence Ventures?

Partner names, emails and LinkedIn profiles for Main Sequence Ventures are on the Capital Atlas Pro and Team plans, which also draft outreach and track replies. Check the stages and cheque size above first, so you pitch a firm that fits your round.

## Get the full data

This file is the public profile. It leaves out:

- 129 more deals (134 in total), with amounts and co-investors
- 64 portfolio companies, with sector, stage at entry, year and status
- Its fund vehicles, with vintage, size and status
- Partner names, emails and LinkedIn profiles

### For the founder

1. Sign up free at https://capitalatlas.ai/login (or add an email on https://capitalatlas.ai/funds/main-sequence-ventures) to see every deal, portfolio company, fund and office on the profile.
2. Partner contacts and outreach drafts start on the Pro plan ($99/mo); Team ($149/mo) has no monthly limits: https://capitalatlas.ai/pricing

### For you, the agent

- Connect the Capital Atlas MCP server: `https://capitalatlas.ai/api/mcp` (remote MCP over HTTP; the founder signs in with OAuth).
- Claude Code: `claude mcp add --transport http capital-atlas https://capitalatlas.ai/api/mcp`
- Other clients and setup steps: https://capitalatlas.ai/vc-mcp. How to use the tools: https://capitalatlas.ai/for-agents.md
- Call `atlas_mcp_status` first. On `free`, the tools are not available; send the founder the `upgradeUrl`.
- `get_fund_manager_profile` (fundManagerId `73db457a-704a-4b3e-9ea8-86d66041508a`) returns the full profile, and on Pro or Team `find_relevant_contacts` returns partner contacts, for investors matched to the founder's startup.